Press release
Hemoglobinopathy Drugs Market Analysis, Size, Current Scenario and Future Prospects
The major factor that is expected to boost the global hemoglobinopathy drugs market includes the increasing incidence and prevalence of sickle cell disease, which will propel the growth of the global hemoglobinopathy treatment drugs market over the forecast period. For instance, according to the data published in Centers for Disease Control and Prevention in October 2019, SCD affects around 100,000 Americans every year. Moreover, as per the same source, around 1 in 13 African-American babies are born with sickle cell trait.
The global hemoglobinopathy drugs market analysis includes some of the key market players such as GlycoMimetics Inc., Pfizer Inc., Anthera Pharmaceuticals Inc., Eli Lilly and Company, and Mast Therapeutics, among others. To maintain a strong position in the market, these market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. For instance, in July 2018, the European Medicines Agency's Committee for Medicinal Products for Human Use granted the bluebird bio LentiGlobin therapy for use in the treatment of hemoglobinopathy disorders among patients.
To Request a Sample of our Report on Hemoglobinopathy Drugs Market: https://www.omrglobal.com/request-sample/hemoglobinopathy-drugs-market
Market Coverage
The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030
Segment Covered
Regions Covered- Globally
Competitive Landscape: GlycoMimetics Inc., Pfizer Inc., Anthera Pharmaceuticals Inc., Eli Lilly and Company, and Mast Therapeutics, among others.
A full Report of Hemoglobinopathy Drugs Market is Available @ https://www.omrglobal.com/industry-reports/hemoglobinopathy-drugs-market
Hemoglobinopathy Drugs Market by Segment
By Type
Hydroxyurea
Glutamine
Zynteglo
Other
By Distribution Channel
Retail Pharmacy
Hospital Pharmacy
Online Pharmacy
Hemoglobinopathy Drugs Market by Region
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of APAC
Rest of the World
Reasons to buy from us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/hemoglobinopathy-drugs-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hemoglobinopathy Drugs Market Analysis, Size, Current Scenario and Future Prospects here
News-ID: 3163528 • Views: …
More Releases from Orion Market Research
Liposome in Cosmetics Market Size Analysis, Competitive Insights, Leading Player …
The global Liposome in Cosmetics Market was valued at approximately USD 2.1 billion in 2023 and is projected to reach around USD 5.3 billion by 2032, reflecting a Compound Annual Growth Rate (CAGR) of about 10.9% from 2024 to 2032.
Liposome in Cosmetics Market Overview
The liposome in cosmetics market is experiencing significant growth, driven by increasing consumer demand for advanced skincare solutions and the rising awareness of the benefits…
Hybrid Memory Cube (HMC) Market Analysis Current Landscape and Future Outlook
The global Hybrid Memory Cube (HMC) Market was valued at approximately USD 1.7 billion in 2023, and it is projected to reach around USD 10.5 billion by 2032. This indicates a Compound Annual Growth Rate (CAGR) of about 22.8% from 2024 to 2032.
Hybrid Memory Cube (HMC) Market Overview
The Hybrid Memory Cube (HMC) market is experiencing significant growth, driven by the increasing demand for high-performance computing solutions across various…
Hardware & Home Improvement Retailers Market Size Unlocking New Opportunities fo …
The global Hardware & Home Improvement Retailers Market was valued at approximately USD 850 billion in 2023, and it is projected to reach around USD 1.2 trillion by 2033. This indicates a Compound Annual Growth Rate (CAGR) of about 3.5% from 2025 to 2033.
Hardware & Home Improvement Retailers Market Overview
The hardware and home improvement retailers market is experiencing steady growth, driven by increasing consumer interest in DIY projects,…
Fuel Dispenser Market Accelerating Growth with Future Market Size Strategies and …
The global Fuel Dispenser Market was valued at approximately USD 3.5 billion in 2023, and it is projected to reach around USD 5.9 billion by 2032. This indicates a Compound Annual Growth Rate (CAGR) of about 6.0% from 2024 to 2032.
Fuel Dispenser Market Overview
The fuel dispenser market is expanding steadily due to the growing demand for advanced, efficient, and safe fueling solutions in both commercial and retail sectors. As…
More Releases for Hemoglobinopathy
The Hemoglobinopathy Market to grow through mobile apps
The Hemoglobinopathy Market is bound to grow at a remarkable rate in the forecast period. Vital Sign monitoring, in combination with wearables, does aid in symptoms check-in as well as education 24/7. There are also hand-held dongles being made available for attaching to smartphones to measure biomarkers for chronic ailments. This monitoring proves to be more cost-effective and convenient in comparison with in-person care. This trend would be prevalent in…
Adult Hemoglobinopathy Testing Market See Incredible Growth During 2026
The worldwide market for adult hemoglobinopathy testing is anticipated to gradually gain momentum over the years to follow. In revenue terms, over the assessment time frame 2026, the worldwide market is estimated to account for a market evaluation of US$ XXX.X Million towards the end of 2026. The worldwide market is likely to expand at a X% CAGR all through the calculated period 2026.
Hemoglobinopathy is typically an inherited disease, incorporating…
Hemoglobinopathy Market will Surpass US$ 788.2 million by 2024
A considerable proportion of global population succumbs to genetic implications that are either inherently present in the body or are developed over time. Hemoglobinopathy, regrettably, is among such genetic defects hampering the health of millions. Medical organizations and healthcare facilities in the world continue to tackle the spate of hemoglobinopathy by developing effective treatments and drugs. In most cases, the occurrence of hemoglobinopathy is distinctly inherited as a part of…
Hemoglobinopathy Market Estimated to Flourish by 2024
Most health insurance companies, including government programs in the U.S. and Europe provide insurance coverage for hemoglobinopathy therapy under the CPT code. This creates a favorable environment for the growth of the global hemoglobinopathy market. Various government initiatives are being carried out for detection and management of hemoglobinopathy in high disease prevalence regions across the globe, giving a fillip to the global hemoglobinopathy market.
Advancements in diagnosis techniques have led…
Hemoglobinopathy Market Stood at US$ 788.2 Mn by 2024
The global hemoglobinopathy market is segmented based on indication type, test type, end users, and region. Based on indication, the market is segmented into sickle cell disease, alpha thalassemia, and beta thalassemia. Beta thalassemia segment is expected to register a significant CAGR of 8.7% during the forecast period. Sickle cell disease segment is anticipated to grow with a CAGR of 8.3% over the forecast period.
The market has been segmented…
Hemoglobinopathy Market Predicted to Rise at 8.3% CAGR
Some key players in the global hemoglobinopathy market identified in the report include Abbott Diagnostics, Bio-Rad Laboratories Inc., Danaher Corporation, Mindray Medical International Ltd., Nexcelom Bioscience LLC., Nihon Kohden Corporation, PerkinElmer Inc., Siemens Healthineers, and Sysmex Corporation. The individual strategies of these companies in terms of increasing focus on rare diseases, initiatives to increase disease awareness, and enhancing distribution base have been discussed. The report concludes with strategic recommendations for…
